HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph H Antin Selected Research

Proteins (Proteins, Gene)

7/2016Ipilimumab for Patients with Relapse after Allogeneic Transplantation.
1/2016Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.
3/2015Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions.
2/2012Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.
10/2008The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph H Antin Research Topics

Disease

95Graft vs Host Disease (Graft-Versus-Host Disease)
12/2022 - 10/2002
45Bronchiolitis Obliterans Syndrome
11/2022 - 04/2004
32Neoplasms (Cancer)
01/2022 - 08/2003
24Leukemia
12/2022 - 01/2004
23Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 09/2003
21Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2022 - 09/2003
20Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2021 - 09/2003
13BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2015 - 03/2002
12Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
11/2022 - 02/2010
11Infections
01/2022 - 07/2002
11Lymphoma (Lymphomas)
01/2021 - 07/2007
10Aplastic Anemia (Anemia, Hypoplastic)
10/2019 - 05/2007
5Iron Overload
08/2014 - 05/2007
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020 - 10/2006
4B-Cell Lymphoma (Lymphoma, B Cell)
12/2019 - 01/2016
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2019 - 03/2009
3Bronchiolitis Obliterans
12/2022 - 02/2012
3Viremia
01/2022 - 05/2010
3Thrombotic Microangiopathies
01/2020 - 07/2005
3Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2017 - 04/2008
3Mycoses (Diseases, Fungus)
09/2012 - 05/2006
3Multiple Myeloma
12/2011 - 12/2004
3Pneumonia (Pneumonitis)
10/2008 - 12/2002
2Injection Site Reaction
12/2022 - 11/2017
2Hematuria
11/2022 - 12/2020
2Hypotension (Low Blood Pressure)
11/2022 - 03/2016
2Cytokine Release Syndrome
01/2022 - 01/2021
2Cytopenia
01/2021 - 12/2020
2Acute Kidney Injury (Acute Renal Failure)
01/2020 - 01/2019
2Virus Diseases (Viral Diseases)
01/2020 - 06/2013
2Inflammation (Inflammations)
01/2018 - 10/2008
2Fibrosis (Cirrhosis)
01/2017 - 02/2012
2Exanthema (Rash)
02/2014 - 03/2011
2Colitis
08/2013 - 09/2011
2Disease Progression
12/2011 - 02/2010
2Acute Lung Injury
10/2008 - 12/2002
2Mucositis
05/2005 - 05/2004

Drug/Important Bio-Agent (IBA)

26Tacrolimus (Prograf)FDA LinkGeneric
12/2022 - 09/2003
25Sirolimus (Rapamycin)FDA Link
01/2020 - 09/2003
19Methotrexate (Mexate)FDA LinkGeneric
12/2022 - 09/2003
15SteroidsIBA
11/2022 - 08/2004
11Interleukin-2 (IL2)IBA
11/2022 - 12/2011
11Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 09/2003
9fludarabineIBA
01/2020 - 04/2008
9Calcineurin InhibitorsIBA
01/2019 - 05/2004
8VaccinesIBA
12/2022 - 02/2003
8Busulfan (Busulfex)FDA Link
01/2020 - 12/2002
8AntigensIBA
01/2018 - 04/2004
7defibrotideIBA
10/2018 - 07/2010
6Adrenal Cortex Hormones (Corticosteroids)IBA
05/2021 - 09/2004
6Bortezomib (Velcade)FDA Link
03/2019 - 10/2009
5Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2021 - 05/2009
5Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2021 - 05/2009
5Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2020 - 06/2013
5HLA Antigens (Human Leukocyte Antigens)IBA
01/2020 - 07/2006
5Proteins (Proteins, Gene)FDA Link
07/2016 - 10/2008
5Minor Histocompatibility AntigensIBA
03/2010 - 01/2003
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2022 - 09/2009
4CytokinesIBA
01/2022 - 11/2002
4IronIBA
11/2021 - 06/2011
4trans-crotonin (CTN)IBA
11/2019 - 12/2011
4Biological ProductsIBA
11/2017 - 09/2009
4DNA (Deoxyribonucleic Acid)IBA
12/2016 - 05/2010
3Biomarkers (Surrogate Marker)IBA
01/2020 - 06/2012
3Pharmaceutical PreparationsIBA
03/2019 - 05/2006
3Sorafenib (BAY 43-9006)FDA Link
04/2018 - 12/2014
3AntibodiesIBA
12/2017 - 04/2005
3HLA-A Antigens (HLA-A)IBA
09/2015 - 04/2009
3Ferritins (Ferritin)IBA
08/2014 - 06/2011
3B-Cell Activating FactorIBA
05/2014 - 10/2007
3Rituximab (Mabthera)FDA Link
06/2013 - 07/2006
2Alemtuzumab (Campath)FDA Link
04/2022 - 05/2013
2IpilimumabIBA
10/2021 - 07/2016
2Natalizumab (Tysabri)FDA Link
05/2021 - 01/2021
2InterferonsIBA
12/2020 - 01/2016
2ibrutinibIBA
01/2020 - 11/2014
2Phosphotransferases (Kinase)IBA
01/2020 - 12/2008
2Transcription Factors (Transcription Factor)IBA
01/2019 - 01/2019
2Interleukin-15 (Interleukin 15)IBA
04/2018 - 01/2018
2Monoclonal AntibodiesIBA
01/2017 - 09/2003
2Immune Checkpoint InhibitorsIBA
01/2017 - 07/2016
2Immunoglobulins (Immunoglobulin)IBA
06/2014 - 02/2012
2TOR Serine-Threonine KinasesIBA
12/2008 - 09/2004
2Imatinib Mesylate (Gleevec)FDA Link
10/2008 - 08/2004
2Polysaccharides (Glycans)IBA
03/2005 - 02/2003
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
12/2022
1ChromatinIBA
12/2022

Therapy/Procedure

86Hematopoietic Stem Cell Transplantation
11/2022 - 07/2002
54Transplantation
01/2022 - 03/2002
52Therapeutics
11/2022 - 01/2002
43Stem Cell Transplantation
12/2020 - 04/2002
32Cell Transplantation
10/2022 - 02/2003
15Homologous Transplantation
04/2022 - 11/2003
10Drug Therapy (Chemotherapy)
01/2021 - 10/2006
10Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2019 - 03/2002
6Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2016 - 05/2004
3Immunotherapy
01/2022 - 01/2006
3Aftercare (After-Treatment)
01/2014 - 01/2010
2Platelet Transfusion (Blood Platelet Transfusions)
01/2020 - 01/2019
2Chemoradiotherapy
01/2018 - 05/2005